A recent meta-analysis of studies investigating IP-10 as a potential biomarker for SLE/LN concluded that urinary, but not serum levels of IP-10 were significantly elevated in patients with active-LN versus active-SLE/without LN [14]. The gene discussed is CXCL10; the disease is systemic lupus erythematosus.